大葉大學圖書館 |

Multifaceted roles of crystallography in modern drug discovery[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.19
書名/作者:	Multifaceted roles of crystallography in modern drug discovery/ edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
其他作者:	Scapin, Giovanna.
團體作者:	Clark Conference
出版者:	Dordrecht : : Springer Netherlands :, 2015.
面頁冊數:	xi, 240 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Pharmaceutical chemistry
標題:	Drugs - Congresses. - Design
標題:	Drug development - Handbooks, manuals, etc.
標題:	Crystallography
標題:	Structural bioinformatics - Congresses.
標題:	Life Sciences.
標題:	Protein-Ligand Interactions.
標題:	Medicinal Chemistry.
標題:	Molecular Medicine.
標題:	Theoretical and Computational Chemistry.
標題:	Crystallography.
ISBN:	9789401797191 (electronic bk.)
ISBN:	9789401797184 (paper)
內容註:	Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.
摘要、提要註:	The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.
電子資源:	http://dx.doi.org/10.1007/978-94-017-9719-1

Multifaceted roles of crystallography in modern drug discovery[electronic resource] /
Multifaceted roles of crystallography in modern drug discovery[electronic resource] /edited by Giovanna Scapin, Disha Patel, Eddy Arnold. - Dordrecht :Springer Netherlands :2015. - xi, 240 p. :ill. (some col.), digital ;24 cm. - NATO science for peace and security, series A, Chemistry and biology,1874-6489. - NATO science for peace and security series.Series A,Chemistry and biology..

Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.

The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.

ISBN: 9789401797191 (electronic bk.)

Standard No.: 10.1007/978-94-017-9719-1doiSubjects--Topical Terms:

197116
Pharmaceutical chemistry

LC Class. No.: RS420

Dewey Class. No.: 615.19

Multifaceted roles of crystallography in modern drug discovery[electronic resource] /
LDR:03741nam a2200301 a 4500 001 426536
003 DE-He213
005 20150911160737.0
006 m d
007 cr nn 008maaau
008 151119s2015 ne s 0 eng d
020 $a 9789401797191 (electronic bk.)
020 $a 9789401797184 (paper)
024 7 $a 10.1007/978-94-017-9719-1 $2 doi
035 $a 978-94-017-9719-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RS420
082 0 4 $a 615.19 $2 23
090 $a RS420 $b .N279 2014
111 2 $a Clark Conference $d (2005 : $c Sterling and Francine Clark Art Institute) $3 347558
245 1 0 $a Multifaceted roles of crystallography in modern drug discovery $h [electronic resource] / $c edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a xi, 240 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a NATO science for peace and security, series A, Chemistry and biology, $x 1874-6489
505 0 $a Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.
520 $a The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.
650 0 $a Pharmaceutical chemistry $3 197116
650 0 $a Drugs $x Design $v Congresses. $3 411882
650 0 $a Drug development $v Handbooks, manuals, etc. $3 438126
650 0 $a Crystallography $3 143711
650 0 $a Structural bioinformatics $v Congresses. $3 606678
650 1 4 $a Life Sciences. $3 463509
650 2 4 $a Protein-Ligand Interactions. $3 465204
650 2 4 $a Medicinal Chemistry. $3 463754
650 2 4 $a Molecular Medicine. $3 463625
650 2 4 $a Theoretical and Computational Chemistry. $3 464488
650 2 4 $a Crystallography. $3 394186
700 1 $a Scapin, Giovanna. $3 606676
700 1 $a Patel, Disha. $3 606677
700 1 $a Arnold, Eddy. $3 466867
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a NATO science for peace and security series. $n Series A, $p Chemistry and biology. $3 466671
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-9719-1
950 $a Biomedical and Life Sciences (Springer-11642)